Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810484 · ClinicalTrials.gov registry record · NA
Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01810484: Completed NA study, sponsored by Ulthera.
NCT01810484 is a NA study that has completed, run by Ulthera. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01810484, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Up to 20 subjects will be enrolled. Enrolled subjects will receive one of three study treatments in the abdominal region: Ultherapy® only, Ultherapy® and CO2 laser treatment, or CO2 laser treatment only. Follow-up visit will occur at 14, 90 and 180 days post-treatment. Study images will be obtained pre-treatment, approximately 30 minutes post-treatment, and at each follow-up visit.
Primary Outcome
A masked, qualitative assessment of change from baseline in the areas treated based a review of 2D images obtained at baseline and 90 days post-treatment.
Interventions
- DEVICE Ultherapy® treatment only
- DEVICE Ultherapy® treatment and CO2 laser treatment
- DEVICE CO2 Laser treatment only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT01810484 record still lists
NCT01810484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Ultherapy® treatment only is the first listed.
NCT01810484 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01810484 about?
NCT01810484 is a clinical study titled "Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment". Up to 20 subjects will be enrolled. Enrolled subjects will receive one of three study treatments in the abdominal region: Ultherapy® only, Ultherapy® and CO2 laser treatment, or CO2 laser treatment only. Follow-up visit will occur at 14, 90 and 180 days post-treatment. Study images will be obtained ...
What is the current status of trial NCT01810484?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2013-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01810484?
The interventions under investigation include: Ultherapy® treatment only (DEVICE), Ultherapy® treatment and CO2 laser treatment (DEVICE), CO2 Laser treatment only (DEVICE).
Who is sponsoring clinical trial NCT01810484?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01810484's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia